微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2.43% | 23.98% | 35% | 95/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.8% | -43.75% | 56.52% | 87/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.15% | -59.36% | -36.46% | 89/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.81% | 178.7% | -7.65% | 91/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 1.96% | 88.46% | -38.75% | 106/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.2% | 14.7% | 13.07% | 67/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.83% | 25.22% | 223.04% | 39/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -2.3% | -151.8% | -321.15% | 115/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 1.04% | -81.53% | -62.72% | 105/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.79% | -36.16% | 23.45% | 74/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.26% | -38.75% | -49.1% | 54/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 4.44% | -82.48% | -21.14% | 83/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 5.63% | -77.66% | 28.83% | 73/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 4.37% | -73.96% | 18.43% | 64/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.69% | -52.99% | -85.44% | 30/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 25.34% | -23.49% | 0.56% | 10/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 25.2% | -5.65% | 50.18% | 5/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 16.78% | 10.18% | 113.76% | 5/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 7.85% | -7.32% | -76.3% | 6/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 33.12% | 153.79% | 24% | 2/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 26.71% | 347.4% | 75.38% | 2/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 15.23% | 459.93% | 79.81% | 3/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 8.47% | 439.49% | -35.1% | 2/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 13.05% | 8.39% | 118.59% | 36/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.97% | -63.6% | 119.49% | 56/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.72% | -75.76% | 73.25% | 75/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.57% | -81.33% | -86.96% | 66/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 12.04% | -43.42% | -26.59% | 40/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 16.4% | 2% | 46.17% | 10/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 11.22% | 2% | -47.27% | 11/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 21.28% | 126.14% | 153.03% | 22/160 | 6.33% | 河化股份 | 54.24% | 行业排名> |
| 2016-03-31 | 8.41% | 2% | -10.63% | 2/160 | 2.65% | 华东医药 | 7.2% | 行业排名> |
| 2015-12-31 | 9.41% | 61.68% | 61.68% | 53/160 | 11.35% | 南新制药 | 81.7% | 行业排名> |